Brief: Dyadic International Announces Sale Of Equity Interest In Alphazyme
Jan 19 (Reuters) - Dyadic International Inc DYAI.O :
* DYADIC ANNOUNCES SALE OF EQUITY INTEREST IN ALPHAZYME
* DYADIC ANNOUNCES SALE OF EQUITY INTEREST IN ALPHAZYME
* DYADIC INTERNATIONAL INC - IT RECEIVED APPROXIMATELY $1.27
MILLION IN CONNECTION WITH SALE OF ITS EQUITY INTEREST IN
ALPHAZYME LLC
* DYADIC INTERNATIONAL INC - DYADIC RECEIVED ITS EQUITY AS
PART OF
CONSIDERATION FOR GRANT OF A NON-EXCLUSIVE LICENSE TO CERTAIN OF
DYADIC'S TECHNOLOGY
Source text for Eikon: ID:nGNX8SlYSV
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development